Class / Patent application number | Description | Number of patent applications / Date published |
623600160 | Having cellular growth inhibitors | 7 |
20080208334 | COATED MEDICAL IMPLANTS AND LENSES - Coated medical implants have an implant body configured for securing in or adjacent to body tissue of a patient. The implant body has an implant surface and a coating is formed on at least a portion of the implant surface. The coating includes a coating outer surface of a first chemical component that is chemically bonded to a carboxylate functionality of a second chemical component. The second chemical component is immobilized by amide linkage to an underlying third chemical component that is plasma coated directly onto implant body surfaces. The coating either inhibits or prevents the adhesion of protein and/or cellular proliferation or may be a non-fouling coating. | 08-28-2008 |
20080288064 | IOL For Reducing Secondary Opacification - An IOL implantable in an eye comprising an optic having an optical portion for directing light toward the retina of the eye and a cell barrier portion for inhibiting cell growth from the eye in front of or in back of the optical portion. The cell barrier portion circumscribes the optical portion, is incapable of focusing light on the retina and includes an irregularly configured structure, for example, irregular grooves. At least one elongated fixation member is coupled to the optic for use in fixing the optic in the eye. | 11-20-2008 |
20100222879 | INTRAOCULAR LENS FOR CAPSULAR BAG - An intraocular lens to be implanted into the capsular bag after ablation of the crystalline lens includes a central optical portion and a haptic portion including haptic members arranged on the periphery of the optical part and for positioning the intraocular lens in the capsular bag. On the one hand, the posterior surface of the optical portion includes a sharp ridge at the peripheral edge and, on the other hand, the posterior surface of the haptic members includes a proximal area in the vicinity of the peripheral edge of the optical portion, each proximal area including at least one tooth extending substantially along the entire width of each haptic member, the tooth or teeth having a sharp edge that becomes serrated in the posterior capsule in order to limit the migration of the epithelial cells of the haptic members towards the optical portion. | 09-02-2010 |
20120232649 | Intraocular Lens Cell Migration Inhibition System - Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye. | 09-13-2012 |
20140288645 | Cell Migration Inhibition System - Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye. | 09-25-2014 |
20150342725 | Micropatterned Intraocular Implant - Generally, an intraocular implant having on the external surface a plurality of pattern surface elements disposed in spaced apart relation defining a tortuous pathway adapted to control a flow of fluid, or a flow of particles suspended in a fluid, or inhibits the growth or migration of cells. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits growth or migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye. | 12-03-2015 |
20160081792 | Intraocular Cell Migration Inhibition System - Generally, an intraocular implant and methods for treating an ocular condition. In particular, an intraocular implant which implanted between an intraocular lens and the surface of the posterior capsule of the eye inhibits migration of residual lens epithelial cells after cataract surgery by providing structural barriers to reduce posterior capsule opacification of the eye. | 03-24-2016 |